Nanoscope Therapeutics Strengthens Research and Development Leadership with Appointment of Najam Sharif, PhD, DSc.

/PRNewswire/ -- Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases, today announced...

Related Keywords

Dallas ,Texas ,United States ,United Kingdom ,Singapore ,British ,Naj Sharif ,Psulagna Bhattacharya ,Najam Sharif ,Ernsth Barany ,Clinical Sciences ,Novartis ,Roger Vogel Award For Pharmaceutical Research ,Syntex Pharma Roche Pharmaceutical Corp ,Nanoscope Therapeutics Inc ,Global Research ,Scientific Advisory Board Of The Glaucoma Foundation ,Association For Research ,Falcon Research ,British Pharmacological Society ,University Of Southampton United Kingdom ,Association For Ocular Pharmacology ,Synaptic Pharmaceutical Corp ,Institute Of Ophthalmology At University College London ,Global Alliances External Research ,Global Biomedical Sciences Head Of Glaucoma ,Data Sciences ,Vice President ,Chief Executive Officer ,Global Biomedical Sciences ,Global Alliances ,External Research ,Alcon Research Novartis ,Syntex Pharma ,Roche Pharmaceutical ,Ocular Pharmacology ,British Pharmacological ,Scientific Advisory Board ,Glaucoma Foundation ,University College ,Roger Vogel ,Pharmaceutical Research ,Sir James Black Award ,Nanoscope Therapeutics ,